Daiichi Sankyo Gains First Approval For Oral Factor Xa Inhibitor In Japan

TOKYO - Daiichi Sankyo Co. Ltd. received official approval for the first oral Factor Xa inhibitor in Japan. Following a recommendation for approval in March, Japan's Ministry of Health, Labor and Welfare approved Lixiana (edoxaban) for prevention of post-surgery thromboembolism April 22